A Study of Benralizumab in Patients With Eosinophilic Esophagitis

PHASE3TerminatedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

September 19, 2022

Study Completion Date

February 6, 2023

Conditions
Eosinophilic Esophagitis
Interventions
BIOLOGICAL

Benralizumab

Solution for injection in a single accessorized prefilled syringe (APFS) will be administered subcutaneously (SC), 1 mL fill volume

BIOLOGICAL

Matching placebo

Matching placebo solution for injection in APFS, 1 mL fill volume. Placebo solution will be administered subcutaneously (SC), 1 mL fill volume

Trial Locations (78)

10029

Research Site, New York

15401

Research Site, Uniontown

16126

Research Site, Genova

18341

Research Site, Afula

19104

Research Site, Philadelphia

20089

Research Site, Rozzano

21079

Research Site, Dijon

21162

Research Site, White Marsh

23219

Research Site, Richmond

27157

Research Site, Winston-Salem

27514

Research Site, Chapel Hill

28006

Research Site, Madrid

28031

Research Site, Madrid

28040

Research Site, Madrid

31059

Research Site, Toulouse

33600

Research Site, Pessac

33709

Research Site, St. Petersburg

37134

Research Site, Verona

42859

Research Site, Remscheid

45229

Research Site, Cincinnati

48013

Research Site, Bilbao

48047

Research Site, Chesterfield

50134

Research Site, Florence

55905

Research Site, Rochester

56124

Research Site, Pisa

58100

Research Site, Holon

59037

Research Site, Lille

60068

Research Site, Park Ridge

60590

Research Site, Frankfurt

60611

Research Site, Chicago

61761

Research Site, Normal

64239

Research Site, Tel Aviv

68510

Research Site, Lincoln

69437

Research Site, Lyon

72202

Research Site, Little Rock

80131

Research Site, Napoli

80337

Research Site, München

81675

Research Site, München

84107

Research Site, Salt Lake City

84132

Research Site, Salt Lake City

92151

Research Site, Suresnes

105066

Research Site, Moscow

111123

Research Site, Moscow

119992

Research Site, Moscow

454091

Research Site, Chelyabinsk

4428164

Research Site, Kfar Saba

4920235

Research Site, Petah Tikva

30322-1013

Research Site, Atlanta

02111

Research Site, Boston

02115

Research Site, Boston

07712

Research Site, Ocean City

L8S 1G5

Research Site, Hamilton

N6A 5W9

Research Site, London

K1H 1E4

Research Site, Ottawa

N8X 2G1

Research Site, Windsor

F-59037

Research Site, Lille

260-0877

Research Site, Chiba

693-8501

Research Site, Izumo-shi

371-8511

Research Site, Maebashi

545-8586

Research Site, Osaka

1105 AZ

Research Site, Amsterdam

3435 CM

Research Site, Nieuwegein

6525 GA

Research Site, Nijmegen

80-214

Research Site, Gdansk

44-190

Research Site, Knurów

93-338

Research Site, Lodz

20-582

Research Site, Lublin

35-302

Research Site, Rzeszów

71-434

Research Site, Szczecin

04-141

Research Site, Warsaw

50-449

Research Site, Wroclaw

08916

Research Site, Badalona

08035

Research Site, Barcelona

08036

Research Site, Barcelona

BN2 5BE

Research Site, Brighton

DL3 6HX

Research Site, Darlington

E1 2AJ

Research Site, London

SW17 0RE

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY